KEYTRUDA 25 mg/mL concentrate for solution for infusion, TEDOPI
GINECO-OV244b
Phase 2 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion, TEDOPI for Platinum sensitive recurrent ovarian cancer is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Platinum sensitive recurrent ovarian cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active